• RIPA Lysis Buffer Strong: Reliable Cell Assays

  2026-09-01

  Learn how RIPA Lysis Buffer (Strong, without inhibitors), SKU K1120, addresses inconsistent protein recovery after cell viability, proliferation, and cytotoxicity experiments. This scenario-based guide covers assay compatibility, inhibitor customization, sample normalization, protocol parameters, and practical vendor selection.

• Cy5 maleimide (non-sulfonated) Workflow Guide

  2026-09-01

  Cy5 maleimide (non-sulfonated) provides a practical route for covalent fluorescent labeling of accessible thiol groups, especially cysteine residues, in peptides and proteins. Its low aqueous solubility makes solvent handling and cleanup important, and target-specific labeling performance should be validated rather than assumed.

• mCherry mRNA Workflows for Reporter Assays

  2026-08-31

  Use Cap 1, 5mCTP, and ψUTP chemistry to establish a bright, transient red fluorescent protein expression control for imaging, delivery benchmarking, and reporter assays. The workflow also shows how mCherry mRNA can complement—not replace—the bacterial NADH/NAD+ biosensor strategy reported in the reference study.

• JNJ-10198409: PDGF Receptor Inhibitor Workflows

  2026-08-31

  JNJ-10198409 provides a nanomolar starting point for dissecting PDGF-BB receptor phosphorylation, smooth-muscle-cell proliferation, migration, and angiogenic phenotypes. This guide combines dose–response design, time-resolved signaling measurements, practical troubleshooting, and a carefully bounded comparison with recent host-kinase research.

• Human iPSC Intestinal Organoids for Pharmacokinetics

  2026-08-30

  Saito and colleagues developed a direct three-dimensional culture workflow for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids could be propagated, cryopreserved, and converted into epithelial monolayers containing functionally active enterocyte-like cells, supporting more human-relevant studies of intestinal drug metabolism and transport.

• GSK 2837808A: LDHA Inhibition Workflows

  2026-08-29

  Use GSK 2837808A to connect LDHA activity with lactate release, glucose consumption, and tumor-cell signaling in controlled cell-based experiments. This practical guide combines metabolic readouts with the NAT1–ENO1–lactate–PD-L1 framework while separating established product data from hypothesis-generating colorectal cancer applications.

• HyperScript™ Reverse Transcriptase in HCC RT-qPCR

  2026-08-28

  Learn how HyperScript™ Reverse Transcriptase can strengthen RNA to cDNA conversion for hepatocellular carcinoma RT-qPCR, especially when transcripts are scarce or structurally challenging. This paper-guided workflow separates true licoricidin biology from reverse-transcription and assay-design artifacts.

• A23187, Free Acid: Calcium Ionophore Workflows

  2026-08-28

  A23187, free acid provides a practical way to raise intracellular Ca2+ while connecting calcium signaling with apoptosis, metabolism, and contractility assays. This guide translates the reference study’s viability framework into controlled workflows, orthogonal readouts, and troubleshooting decisions for more interpretable in vitro experiments.

• Octenidine: From Membrane Mechanism to Translation

  2026-08-27

  Octenidine dihydrochloride is more than a benchmark antiseptic: its cationic amphiphilic design makes microbial membrane disruption experimentally tractable while exposing important questions about selectivity, formulation, and translational performance. This article connects mechanism, assay strategy, emerging gemini quaternary ammonium chemistry, and practical research planning.

• CFDA SE Cell Tracer Kit: Practical Guide

  2026-08-27

  The CFDA SE Cell Tracer Kit provides stable fluorescent labeling for tracking live cells across several days, supporting cell proliferation studies and cell lineage tracing. It is intended for persistent covalent marking rather than reversible, short-term labeling, and staining conditions should be optimized for each cell type.

• 2-Hydroxypropyl-β-cyclodextrin Workflow Guide

  2026-08-26

  2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide used to improve the aqueous handling of poorly soluble hydrophobic compounds, especially molecules with aromatic or phenyl groups. It is best restricted to validated pharmaceutical and biochemical solubility workflows or use as a drug formulation excipient; the supplied product information does not establish therapeutic, permeability, or in vivo bioavailability outcomes.

• Reparixin: From CXCR1 Signaling to Assay Design

  2026-08-26

  Reparixin is a CXCR1/2 inhibitor that enables causal analysis of CXCL8-driven signaling across neutrophil and tumor models. This guide translates recent MRSA extracellular-vesicle findings into rigorous assay strategies while defining the limits of cross-model interpretation.

• 2X Taq PCR Master Mix for Cassava Genotyping

  2026-08-25

  Use a dye-containing Taq formulation to streamline cassava genotyping, construct checks, and endpoint PCR without a separate loading-buffer step. Its adenine-overhang chemistry also supports TA cloning, while the reference study provides a practical framework for selecting stress-related Metip targets and controls.

• Nebivolol Beyond β1 Blockade: A Translational Lens

  2026-08-25

  Nebivolol hydrochloride offers a precise β1-receptor perturbation tool, while recent yeast data clarify what it does not do: inhibit mTOR under a sensitized screening paradigm.

• iPSC Organoids Reveal Pan-Genotype HEV Tropism

  2026-08-24

  A 2025 Gut study establishes iPSC-derived liver, intestinal and brain organoids as multilineage models that sustain complete replication of clinical HEV genotypes 1, 3 and 4. The platform maps previously under-characterized cellular tropism, tissue injury and gut–liver–gut transmission, while providing a physiologically relevant system for antiviral evaluation.

8594 records 1/573 page Next 12345 下5页 Last page